First Horizon Corporation’s Aurinia Pharmaceuticals AUPH Stock Holding History

First Horizon Corporation’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$288	Hold	17	–	–	﹤0.01%	1483
2026 Q1	$252	Hold	17	–	–	﹤0.01%	1427
2025 Q4	$271	Hold	17	–	–	﹤0.01%	1447
2025 Q3	$188	Buy	+17	New	+$186	﹤0.01%	1397
2021 Q2	$1K	Hold	80	–	–	﹤0.01%	983
2021 Q1	$1K	Buy	+80	New	+$1.16K	﹤0.01%	964

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Horizon Corporation's AUPH Position: Q2 2026 in Review

First Horizon Corporation held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 17 shares worth $288. The position accounts for ﹤0.01% of the portfolio, ranked #1483.

First Horizon Corporation first reported a position in AUPH in Q1 2021 and has held it in 6 quarters since. The position peaked at $1K in Q2 2021. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

First Horizon Corporation held 17 shares of Aurinia Pharmaceuticals worth $288 as of Q2 2026.
First Horizon Corporation left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1483 holding.
First Horizon Corporation first reported a position in Aurinia Pharmaceuticals in Q1 2021 and has held it in 6 quarters since.
First Horizon Corporation's Aurinia Pharmaceuticals position peaked at $1K in Q2 2021.
282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.